Invesco Ltd. Kiniksa Pharmaceuticals, Ltd. Transaction History

Invesco Ltd.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$17.63 - $21.74 $734,783 - $906,079	41,678 Added 329.68%	54,320 $1.07 Million
Q4 2023 Feb 12, 2024	SELL	$14.37 - $19.07 $2.87 Million - $3.81 Million	-199,954 Reduced 94.05%	12,642 $221,000
Q3 2023 Nov 13, 2023	BUY	$13.62 - $20.2 $2.9 Million - $4.29 Million	212,596 New	212,596 $3.69 Million
Q1 2023 May 12, 2023	SELL	$10.7 - $15.79 $2.14 Million - $3.17 Million	-200,449 Reduced 93.86%	13,109 $141,000
Q4 2022 Feb 13, 2023	BUY	$11.42 - $17.05 $2.28 Million - $3.4 Million	199,703 Added 1441.38%	213,558 $3.2 Million
Q3 2022 Nov 14, 2022	BUY	$9.76 - $13.41 $15,830 - $21,751	1,622 Added 13.26%	13,855 $178,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $6,361 - $9,550	837 Added 7.34%	12,233 $118,000
Q1 2022 May 16, 2022	BUY	$9.3 - $12.37 $1,450 - $1,929	156 Added 1.39%	11,396 $113,000
Q4 2021 Feb 14, 2022	SELL	$10.39 - $15.15 $15,543 - $22,664	-1,496 Reduced 11.75%	11,240 $133,000
Q3 2021 Nov 15, 2021	BUY	$11.39 - $16.23 $19,943 - $28,418	1,751 Added 15.94%	12,736 $145,000
Q2 2021 Aug 17, 2021	BUY	$13.22 - $19.09 $145,221 - $209,703	10,985 New	10,985 $153,000
Q3 2020 Nov 16, 2020	SELL	$15.21 - $25.53 $761,625 - $1.28 Million	-50,074 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$15.08 - $26.0 $755,115 - $1.3 Million	50,074 New	50,074 $1.28 Million
Q1 2019 May 15, 2019	SELL	$15.93 - $26.59 $706,702 - $1.18 Million	-44,363 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$16.25 - $28.09 $720,898 - $1.25 Million	44,363 New	44,363 $1.25 Million

1.95M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $751M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.